FindTrial
Sign In

Clinical study for diagnosis of benign and malignant pulmonary nodules based on ctDNA mutation, methylation and t-cell receptor sequencing

Clinical study for diagnosis of benign and malignant pulmonary nodules based on ctDNA mutation, methylation and t-cell receptor sequencing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021172
Enrollment
Unknown
Registered
2019-01-31
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign and malignant pulmonary nodules

Interventions

Gold Standard:Pulmonary tissue
Index test:Blood, sputum

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) in patients with confirmed pulmonary nodules by CT, the maximum diameter of pulmonary nodules is 5mm-30mm; 2) patient aged at least 18 years.

Exclusion criteria

Exclusion criteria: 1) imaging examination (including CT, magnetic resonance, PET, bone imaging, etc.) indicates the existence of metastatic tumor evidence outside the lung; 2) pulmonary nodules are benign or malignant without histopathological examination; 3) pregnant woman.

Design outcomes

Primary

MeasureTime frame
Lung benign and malignant nodules differentiation model;—

Countries

China

Contacts

Public ContactWeimin LI

West China Clinical Medical College, Sichuan University

weimi003@163.com+86 18980601009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026